Call Us: (1) 608 441-2729 - Email Us info@flugen.com
Twitter
M2SR: The Vaccine
Influenza
Leadership
Executive Team
Board of Directors
Clinical Advisory Board
Investors
News
Contact
Contact
Careers
News
News and opinions
Channel3000.com – Biotech Companies Still Hiring In Tough Economy (VIDEO)
February 28, 2009
Maggie Coluccy
Uncategorized
Print Article
Share this Story
Facebook
Twitter
LinkedIn
Reddit
Digg
Delicious
Google++
E-Mail+
Comments are closed.
Prev Post
Next Post
Recent News
Watch FluGen President & CEO Paul Radspinner speak at the Jefferies 2021 Virtual Healthcare Conference
FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85
UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine
Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice
FluGen’s M2SR Phase 2 Human Challenge Trial Initial Results
(c)2016 FluGen, Inc. All rights reserved.
Twitter
Back to Top
FCOI policy
Comments are closed.